Xeris Pharmaceuticals' Grant - III Round

Xeris Pharmaceuticals raised a round of funding on April 14, 2015. Investors include National Institute of Diabetes and Digestive and Kidney Diseases.

Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's X…

Articles about Xeris Pharmaceuticals' Grant - III Round: